266 related articles for article (PubMed ID: 31969012)
21. Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension.
Bourgeois A; Bonnet S; Breuils-Bonnet S; Habbout K; Paradis R; Tremblay E; Lampron MC; Orcholski ME; Potus F; Bertero T; Peterlini T; Chan SY; Norris KA; Paulin R; Provencher S; Boucherat O
Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1667-1681. PubMed ID: 31092016
[TBL] [Abstract][Full Text] [Related]
22. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
23. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling.
Iwata K; Ikami K; Matsuno K; Yamashita T; Shiba D; Ibi M; Matsumoto M; Katsuyama M; Cui W; Zhang J; Zhu K; Takei N; Kokai Y; Ohneda O; Yokoyama T; Yabe-Nishimura C
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):110-9. PubMed ID: 24233492
[TBL] [Abstract][Full Text] [Related]
24. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
[No Abstract] [Full Text] [Related]
25. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L
Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415
[TBL] [Abstract][Full Text] [Related]
26. Vascular peroxidase 1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation, apoptosis resistance and migration.
You B; Liu Y; Chen J; Huang X; Peng H; Liu Z; Tang Y; Zhang K; Xu Q; Li X; Cheng G; Shi R; Zhang G
Cardiovasc Res; 2018 Jan; 114(1):188-199. PubMed ID: 29186367
[TBL] [Abstract][Full Text] [Related]
27. Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension.
Paulin R; Courboulin A; Meloche J; Mainguy V; Dumas de la Roque E; Saksouk N; Côté J; Provencher S; Sussman MA; Bonnet S
Circulation; 2011 Mar; 123(11):1205-15. PubMed ID: 21382889
[TBL] [Abstract][Full Text] [Related]
28. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
29. Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
Meloche J; Lampron MC; Nadeau V; Maltais M; Potus F; Lambert C; Tremblay E; Vitry G; Breuils-Bonnet S; Boucherat O; Charbonneau E; Provencher S; Paulin R; Bonnet S
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1513-1523. PubMed ID: 28473439
[TBL] [Abstract][Full Text] [Related]
30. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
31. Calpain-2 activates Akt via TGF-β1-mTORC2 pathway in pulmonary artery smooth muscle cells.
Abeyrathna P; Kovacs L; Han W; Su Y
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C24-34. PubMed ID: 27099352
[TBL] [Abstract][Full Text] [Related]
32. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to the development of pulmonary arterial hypertension.
Guo D; Gu J; Jiang H; Ahmed A; Zhang Z; Gu Y
J Mol Cell Cardiol; 2016 Feb; 91():179-87. PubMed ID: 26774701
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
[TBL] [Abstract][Full Text] [Related]
35. HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension.
Boucherat O; Chabot S; Paulin R; Trinh I; Bourgeois A; Potus F; Lampron MC; Lambert C; Breuils-Bonnet S; Nadeau V; Paradis R; Goncharova EA; Provencher S; Bonnet S
Sci Rep; 2017 Jul; 7(1):4546. PubMed ID: 28674407
[TBL] [Abstract][Full Text] [Related]
36. Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension: Novel Effects of an Old Drug.
Siddique MAH; Satoh K; Kurosawa R; Kikuchi N; Elias-Al-Mamun M; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Ueda H; Tokuyama H; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2367-2385. PubMed ID: 31533472
[TBL] [Abstract][Full Text] [Related]
37. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.
Bourgeois A; Lambert C; Habbout K; Ranchoux B; Paquet-Marceau S; Trinh I; Breuils-Bonnet S; Paradis R; Nadeau V; Paulin R; Provencher S; Bonnet S; Boucherat O
J Mol Med (Berl); 2018 Feb; 96(2):223-235. PubMed ID: 29290032
[TBL] [Abstract][Full Text] [Related]
38. RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.
Meloche J; Paulin R; Courboulin A; Lambert C; Barrier M; Bonnet P; Bisserier M; Roy M; Sussman MA; Agharazii M; Bonnet S
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2114-24. PubMed ID: 21680901
[TBL] [Abstract][Full Text] [Related]
39. PDGF/MEK/ERK axis represses Ca
Deng L; Chen J; Wang T; Chen B; Yang L; Liao J; Chen Y; Wang J; Tang H; Yi J; Kang K; Li L; Gou D
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C66-C79. PubMed ID: 32966125
[TBL] [Abstract][Full Text] [Related]
40. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
